Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
{ "Refer2Quit: Helping Household Smokers Quit Through Pediatric Care", "This study, called Refer2Quit, is looking at a new way to help household members who smoke quit tobacco. It uses a system within Children's Hospital of Philadelphia (CHOP) to connect adults who smoke with treatment options. These options include varenicline, nicotine replacement therapy (NRT), quitlines, and a text messaging program called smokefreeTXT, along with counseling. The study wants to see how many people use these treatments and how many successfully quit smoking after 1 and 6 months. You can join if you are 18 or older, use combustible tobacco, and have a cell phone. Children who are CHOP patients are also part of the study.", "design": "This interventional study plans to enroll 3200 participants. Adult participants will be randomly assigned to either the Refer2Quit intervention or a usual care group.", "commitments": "After consenting, you will complete an enrollment step with data collection on demographics, nicotine dependence, and quitting motivation. Your quit rate will be measured at 1 and 6 months.", "compensation": "Not stated in the trial record.", "follow_up": "Participants will be followed for 6 months to measure their combustible tobacco quit rate.", }
- Study design
- Not specified.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Brian P Jenssen, MD, MSHP · PRINCIPAL_INVESTIGATOR · Children's Hospital of Philadelphia
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- The proportion of adult participants who engage in any evidence-based tobacco use treatmentsBaseline, 1 and 6 months
The proportion of adult participants who engage in any evidence-based tobacco use treatments, between the intervention and control arms, by adult participant self-report.
- Combustible tobacco quit rate at 1 and 6 months1 and 6 months
The quit rate, compared between the intervention and control arms, will be assessed by a self-reported 7-day point prevalence smoking abstinence, collected via follow-up survey, and confirmed via breath carbon monoxide (CO) \<5ppm at the time-point